Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease

NeuroToxicology

Volumn 28, Issue 6, 2007, Pages 1200-1207

  Aguilera, Penélope ^a   Chánez Cárdenas, María Elena ^a   Floriano Sánchez, Esaú ^b   Barrera, Diana ^c   Santamaría, Abel ^a   Sánchez González, Dolores Javier ^b   Pérez Severiano, Francisca ^a   Pedraza Chaverrí, José ^d   Maldonado Jiménez, Perla Deyanira ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Universidad del Ejército y Fuerza Aérea E M G S Laboratorio Multidisciplinario de Investigación   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Huntington's disease; Neurotoxicity; Nitric oxide synthase; Quinolinic acid

Indexed keywords

CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; EXCITOTOXICITY; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BASAL GANGLIA; CALCIUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; QUINOLINIC ACID; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

RATTUS;

EID: 35648984462     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2007.07.010     Document Type: Article

References (58)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 (2001) 593-615
2. Ayata C., Ayata G., Hara H., Matthews R.T., Beal M.F., Ferrante R.J., et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci 17 (1997) 6908-6917
3. Bai Y., Ye S., Mortazavi R., Campese V., and Vaziri N.D. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. Am J Physiol Renal Physiol 292 (2007) F974-F980
4. Bazzett T., Geiger A., Coppola B., and Albin R. The neuronal NOS inhibitor L-MIN, but not 7-NINA, reduces neurotoxic effects of chronic intrastriatal administration of quinolinic acid. Brain Res 775 (1997) 229-232
5. Bredt D.S. Molecular characterization of nitric oxide synthase. In: Vincent S. (Ed). Nitric oxide in the nervous system (1995), Academic Press, San Diego 1-16
6. Bredt D.S. Endogenous nitric oxide synthesis: biological function and pathophysiology. Free Radic Res 31 (1999) 577-596
7. Cepeda C., Ariano M.A., Calvert C.R., Flores-Hernandez J., Chandler S.H., Leavitt B.R., et al. NMDA receptor function in mouse models of Huntington disease. J Neurosci Res 66 (2001) 525-539
8. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6 (2000) 797-801
9. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., and Snider S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90 (1993) 9808-9812
10. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., and Snyder S.H. Nitric oxide synthase mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88 (1991) 6368-6371
11. Deckel A.W., Gordinier A., Nuttal D., Tang V., Kuwada C., Freitas R., et al. Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression. Brain Res 919 (2001) 70-81
12. Deckel A.W., Tang V., Nuttal D., Gary K., and Elder R. Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice. Brain Res 939 (2002) 76-86
13. Fagan K.A., Tyler R.C., Sato K., Fouty B.W., Morris Jr. K.G., Huang P.L., et al. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol 277 (1999) L472-L478
14. Fernandez-Hernando C., Fukata M., Bernatchez P.N., Fukata Y., Lin M.I., Bredt D.S., et al. Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 174 (2006) 369-377
15. Ferrante R.J., Kowall N.W., Cipolloni P.B., Storey E., and Beal M.F. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp Neurol 119 (1993) 46-71
16. Forstermann U., Boissel J.P., and Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12 (1998) 773-790
17. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., and Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 (1993) 1273-1286
18. Iwase K., Iyama K., Akagi K., Yano S., Fukunaga K., Miyamoto E., et al. Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization. Brain Res Mol Brain Res 53 (1998) 1-12
19. Iwase K., Miyanaka K., Shimizu A., Nagasaki A., Gotoh T., Mori M., et al. Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J Biol Chem 275 (2000) 11929-11933
20. Izumi Y., Benz A.M., Clifford D.B., and Zorumski C.F. Nitric oxide inhibitors attenuate N-methyl-d-aspartate excitotoxicity in rat hippocampal slices. Neurosci Lett 135 (1992) 227-230
21. Jaffrey S.R., and Snyder S.H. Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol 11 (1995) 417-440
22. Jesko H., Chalimoniuk M., and Strosznajder J.B. Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain. Neurochem Int 42 (2003) 315-322
23. Kalisch B.E., Jhamandas K., Beninger R.J., and Boegman R.J. Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase. Brain Res 817 (1999) 151-162
24. Kone B.C., Kuncewicz T., Zhang W., and Yu Z.Y. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol 285 (2003) F178-F190
25. MacKenzie G.M., Jenner P., and Marsden C.D. Effect of 7-nitro indazole on quinolinic acid-induced striatal toxicity in the rat. Neuroreport 6 (1995) 1789-1794
26. MacKenzie G.M., Jenner P., and Marsden C.D. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience 67 (1995) 357-371
27. Nagafuji T., Sugiyama M., Muto A., Makino T., Miyauchi T., and Nabata H. The neuroprotective effect of a potent and selective inhibitor of the type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. Neuroreport 6 (1995) 1541-1545
28. Noack H., Lindenau J., Rothe F., Asayama K., and Wolf G. Differential expression of superoxide dismutase isoforms in neuronal and glial compartments in the course of excitotoxically mediated neurodegeneration: relation to oxidative and nitrergic stress. Glia 23 (1998) 285-297
29. Norris P.J., Waldvogel H.J., Faull R.L., Love D.R., and Emson P.C. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience 72 (1996) 1037-1047
30. Perez-De La Cruz V., Gonzalez-Cortes C., Galvan-Arzate S., Medina-Campos O.N., Perez-Severiano F., Ali S.F., et al. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: Protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Neuroscience 135 (2005) 463-474
31. Perez-Severiano F., Escalante B., and Rios C. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem Res 23 (1998) 1297-1302
32. Perez-Severiano F., Escalante B., Vergara P., Rios C., and Segovia J. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res 951 (2002) 36-42
33. Pláteník J., Stopka P., Vejrazka M., and Stípek S. Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the fenton reaction. Free Radic Res 34 (2001) 445-459
34. Possel H., Noack H., Putzke J., Wolf G., and Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lypopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32 (2000) 51-59
35. Ratovitski E.A., Alam M.R., Quick R.A., McMillan A., Bao C., Kozlovsky C., et al. Kalirin inhibition of inducible nitric-oxide synthase. J Biol Chem 274 (1999) 993-999
36. Roberts R.C., Ahn A., Swartz K.J., Beal M.F., and Di Figlia M. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp Neurol 124 (1993) 274-282
37. Rodriguez-Martinez E., Camacho A., Maldonado P.D., Pedraza-Chaverri J., Santamaria D., Galvan-Arzate S., et al. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res 858 (2000) 436-439
38. Ryu J.K., Kim S.U., and McLarnon J.G. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease. Exp Neurol 187 (2004) 150-159
39. Ryu J.K., Tran K.C., and McLarnon J.G. Depletion of neutrophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo. Glia 55 (2007) 439-451
40. Santamaria A., and Rios C. MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 159 (1993) 51-54
41. Santamaria D., Espinoza-Gonzalez V., Rios C., and Santamaria A. Nomega-nitro-l-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem Res 24 (1999) 843-848
42. Santamaria A., Galvan-Arzate S., Lisy V., Ali S.F., Duhart H.M., Osorio-Rico L., et al. Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport 12 (2001) 871-874
43. Santamaria A., Jimenez-Capdeville M.E., Camacho A., Rodriguez-Martinez E., Flores A., and Galvan-Arzate S. In vivo hydroxyl radical formation alter quinolinic acid infusion into rat corpus stratum. Neuroreport 12 (2001) 2693-2696
44. Sasaki M., Gonzalez-Zulueta M., Huang H., Herring W.J., Ahn S., Ginty D.D., et al. Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism. Proc Natl Acad Sci USA 97 (2000) 8617-8622
45. Satoh M., Fujimoto S., Haruna Y., Arakawa S., Horike H., Komai N., et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288 (2005) F1144-F1152
46. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., and Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284 (1999) 1845-1848
47. Schmidt H.H., and Walter U. NO at work. Cell 78 (1994) 919-925
48. Schmidt W., Wolf G., Calka J., and Schmidt H.H. Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience 67 (1995) 345-356
49. Schulz J.B., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D.R., et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. Eur J Neurosci 15 (1995) 8419-8429
50. Schwarcz R., Whetsell WOJr, and Mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219 (1983) 316-318
51. Schwartz D., Mendonca M., Schwartz I., Xia Y., Satriano J., Wilson C.B., et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100 (1997) 439-448
52. Schwarcz R. The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol 4 (2004) 12-17
53. Shear D.A., Dong J., Haik-Creguer K.L., Bazzett T.J., Albin R.L., and Dunbar G.L. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Exp Neurol 150 (1998) 305-311
54. Stipek S., Stastny F., Platenik J., Crkovska J., and Zima T. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem Int 30 (1997) 233-237
55. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45 (1993) 309-379
56. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95 (1998) 9220-9225
57. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273 (1998) 25804-25808
58. Zou M.H., Shi C.H., and Cohen R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109 (2002) 817-826